A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Cancer|Ovarian Cancer
Interventions: DRUG: carboplatin|DRUG: paclitaxel|DRUG: pegfilgrastim
Sponsor: Amgen